Philips Medical Systems launched what it describes as the next generation of medical IT systems today at the RSNA meeting. Called Vequion, this family of products is designed to streamline operations by integrating legacy IT systems and multiple
Philips Medical Systems launched what it describes as the next generation of medical IT systems today at the RSNA meeting. Called Vequion, this family of products is designed to streamline operations by integrating legacy IT systems and multiple modalities, regardless of the manufacturer.
Such homogenization typically risks reducing technological capabilities to the lowest common denominator, limiting users' ability to customize system functions. This is not the case for Vequion, according to Philips. The company believes Vequion represents Philips' commitment to eliminate the boundaries that hamper workflow, increase costs, and impede quality of care. It achieves wide-ranging compatibility while allowing customized data management based on individual or departmental preferences.
Among the key elements of Vequion are a user interface compatible with any modality console or workstation and software that recognizes users and presents data in the format each user prefers. ViewForum, one of the new software-based products within the Vequion family, lets customers configure multimodality workstations to their own preferences, combining viewing options, clinical applications, and PACS functionality. The work-in-progress ViewForum Pro will add interactive 3D volume rendering with direct manipulation, as well as the ability to inspect large data sets.
This adaptability and harmonization support department-specific workflow requirements while reducing costs, minimizing staff training, and boosting quality of care by streamlining operations, according to Philips. To ensure optimum compatibility, Philips Professional Services provides customers with integration/interfacing services, systems implementation, clinical consulting, project/program management, and training.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.